Biomedical Engineering Reference
In-Depth Information
GRIMM, M., EYBL, E., GRABENWOGER, M., SPREITZER, H., JAGER, W., GRIMM, G., BOCK, P.,
MULLER, M. M. & WOLNER, E. (1992a) Glutaraldehyde affects biocompatibility of
bioprosthetic heart valves.
Surgery
,
111
, 74-8.
GRIMM, M., GRABENWOGER, M., EYBL, E., MORITZ, A., BOCK, P., MULLER, M. M. & WOLNER,
E. (1992b) Improved biocompatibility of bioprosthetic heart valves by L-glutamic
acid treatment.
J Card Surg
,
7
, 58-64.
GRUBE, E. & BUELLESFELD, L. (2006) BioMatrix Biolimus A9-eluting coronary stent:
a next-generation drug-eluting stent for coronary artery disease.
Expert Rev Med
Devices
,
3
, 731-41.
GULBINS, H., PRITISANAC, A., UHLIG, A., GOLDEMUND, A., MEISER, B. M., REICHART, B. &
DAEBRITZ, S. (2005) Seeding of human endothelial cells on valve containing aortic
mini-roots: development of a seeding device and procedure.
Ann Thorac Surg
,
79
,
2119-26.
GULDNER, N. W., JASMUND, I., ZIMMERMANN, H., HEINLEIN, M., GIRNDT, B., MEIER, V.,
FL USS, F., ROHDE, D., GEBERT, A. & SIEVERS, H. H. (2009) Detoxifi cation and endo-
thelialization of glutaraldehyde-fi xed bovine pericardium with titanium coating:
a new technology for cardiovascular tissue engineering.
Circulation
,
119
,
1653-60.
GUTENSOHN, K., BEYTHIEN, C., BAU, J., MEINERTZ, T. & KUEHNL, P. (1997) Flow cytometric
analysis of coronary stent-induced alterations of platelet antigens in an
in vitro
model.
Thromb Res
,
86
, 49-56.
HAN, Y., JING, Q., XU, B., YANG, L., LIU, H., SHANG, X., JIANG, T., LI, Z., ZHANG, H., LI, H.,
QIU, J., LIU, Y., LI, Y., CHEN, X. & GAO, R. (2009) Safety and effi cacy of biodegradable
polymer-coated sirolimus-eluting stents in 'real-world' practice 18-month clinical
and 9-month angiographic outcomes.
JACC Cardiovasc Interv
,
2
, 303-9.
HANSI, C., ARAB, A., RZANY, A., AHRENS, I., BODE, C. & HEHRLEIN, C. (2009) Differences
of platelet adhesion and thrombus activation on amorphous silicon carbide, mag-
nesium alloy, stainless steel, and cobalt chromium stent surfaces.
Catheter Cardio-
vasc Interv
,
73
, 488-96.
HASHIYA, N., AOKI, M., TACHIBANA, K., TANIYAMA, Y., YAMASAKI, K., HIRAOKA, K., MAKINO,
H., YASUFUMI, K., OGIHARA, T. & MORISHITA, R. (2004) Local delivery of E2F decoy
oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhib-
its intimal hyperplasia after balloon injury in rat carotid artery model.
Biochem
Biophys Res Commun
,
317
, 508-14.
HEDIN, U., BOTTGER, B. A., FORSBERG, E., JOHANSSON, S. & THYBERG, J. (1988) Diverse
effects of fi bronectin and laminin on phenotypic properties of cultured arterial
smooth muscle cells.
J Cell Biol
,
107
, 307.
HEDIN, U., ROY, J., TRAN, P. K., LUNDMARK, K. & RAHMAN, A. (1999) Control of smooth
muscle cell proliferation - the role of the basement membrane.
Thrombosis hae-
mostasis
,
82
Suppl 1, 23.
HEDIN, U., ROY, J. & TRAN, P. K. (2004) Control of smooth muscle cell proliferation in
vascular disease.
Curr Opinion Lipidol
,
15
, 559.
HENDERSON, L. W. & CHENOWETH, D. (1987) Biocompatibility of artifi cial organs: an
overview.
Blood Purif
,
5
, 100-11.
HIRABAYASHI, K., SAITOH, E., IJIMA, H., TAKENAWA, T., KODAMA, M. & HORI, M. (1992)
Infl uence of fi bril length upon ePTFE graft healing and host modifi cation of the
implant.
J Biomed Mater Res
,
26
, 1433-47.
HIROSE, M., KOSUGI, H., NAKAZATO, K. & HAYASHI, T. (1999) Restoration to a quiescent
and contractile phenotype from a proliferative phenotype of myofi broblast-like
Search WWH ::
Custom Search